Gapping up
In reaction to strong earnings/guidance: VDSI +16.2%, SANM +14.6%, ANAD +13.4%, GIGA +11.7%, RGC +11.4%, GIG +11.1%, BWLD +7.7%, ACI +7.3%, IDTI +6.8%, ALSN +5.8%, NURO +5.8%, STAR +5.8%, UBS +5.3%, CBRX +4.9%, NMR +4.9%, CMI +3.7%, CYNO +3.7%, AN +3.5%, SAVE +2.8%, MPWR +2.5%, PH +2.4%, CNX +2.2%, TMUS +2.1%, AMGN +1.9%, PES+1.7%, UHS +1.5%, CNC +1.5%, FSRV +1.4%, TKR +1.3%, SIRI +1.2%, PFE +1.1%, CLF +1%, AMTD +1%, PCAR +0.9%, .
M&A news: TRNX +24.8% (Wright Medical (WMGI) and Tornier announce ~$3.3 bln merger agreement; each share of Wright common stock will be exchanged for 1.0309 ordinary shares of Tornier ), WMGI +1.1%
Other news: RCPT +31% (reports positive Phase 2 results for TOUCHSTONE Trial of RPC1063 in Ulcerative Colitis; Study met primary efficacy and all secondary endpoints with statistical significance for patients on 1 mg dose after 8 weeks of treatment ), MSG +13% (unanimously approves plan to explore possible spin-off; authorizes up to $500 mln of stock repurchases), MDCO +12.7% (wins favorable judgment in Angiomax patent litigation), MDCO +12.7% ( co received a favorable ruling in patent case against Mylan (MYL)), EROC +11.8% (announced Q3 cash distribution of $0.07 per unit; announces common unit repurchase program of up to $100 mln), APPY +8.9% (announces its pivotal APPY1 Test clinical trial data were presented at ACEP14; APPY1 Test exhibited a sensitivity of 96.9%), PTIE +4.6% (following ~53% move lower yesterday on Remoxy news), PBR +3.9% (cont vol), SUNE +3.7% (signed a MOU with the Rajasthan Government aimed at developing Rajasthan as the global hub for solar energy), TSLA +3% (Elon Musk tweets 'Article in WSJ re Tesla sales is incorrect), DRRX +2.6% (following ~45% move lower yesterday on Remoxy news),TOT +2.1% (sells an 8% interest in Gina Krog Field and interests in three minor fields), ANGI +2% (Director disclosed purchase of 15000 shares, worth total of $98.4K), CNI +0.9% (announces plan to buy back shares through private agreements), CRAY +0.9% (awarded $128 mln supercomputer contract from the UK's Met office)
Analyst comments: GPRO +3.3% (initiated with a Outperform at Wedbush), FMSA +2.3% (initiated with an Outperform at Cowen, initiated with a Buy at KeyBanc Capital Mkts amont others), DRYS +1.9% (upgraded to Outperform at Imperial Capital), CRM +1.5% (added to Best Ideas list at Morgan Stanley), CELG +1.5% (added to US 1 list at BofA/Merrill), YDLE +1.1% (initiated with a Buy at Goldman, among others)
In reaction to strong earnings/guidance: VDSI +16.2%, SANM +14.6%, ANAD +13.4%, GIGA +11.7%, RGC +11.4%, GIG +11.1%, BWLD +7.7%, ACI +7.3%, IDTI +6.8%, ALSN +5.8%, NURO +5.8%, STAR +5.8%, UBS +5.3%, CBRX +4.9%, NMR +4.9%, CMI +3.7%, CYNO +3.7%, AN +3.5%, SAVE +2.8%, MPWR +2.5%, PH +2.4%, CNX +2.2%, TMUS +2.1%, AMGN +1.9%, PES+1.7%, UHS +1.5%, CNC +1.5%, FSRV +1.4%, TKR +1.3%, SIRI +1.2%, PFE +1.1%, CLF +1%, AMTD +1%, PCAR +0.9%, .
M&A news: TRNX +24.8% (Wright Medical (WMGI) and Tornier announce ~$3.3 bln merger agreement; each share of Wright common stock will be exchanged for 1.0309 ordinary shares of Tornier ), WMGI +1.1%
Other news: RCPT +31% (reports positive Phase 2 results for TOUCHSTONE Trial of RPC1063 in Ulcerative Colitis; Study met primary efficacy and all secondary endpoints with statistical significance for patients on 1 mg dose after 8 weeks of treatment ), MSG +13% (unanimously approves plan to explore possible spin-off; authorizes up to $500 mln of stock repurchases), MDCO +12.7% (wins favorable judgment in Angiomax patent litigation), MDCO +12.7% ( co received a favorable ruling in patent case against Mylan (MYL)), EROC +11.8% (announced Q3 cash distribution of $0.07 per unit; announces common unit repurchase program of up to $100 mln), APPY +8.9% (announces its pivotal APPY1 Test clinical trial data were presented at ACEP14; APPY1 Test exhibited a sensitivity of 96.9%), PTIE +4.6% (following ~53% move lower yesterday on Remoxy news), PBR +3.9% (cont vol), SUNE +3.7% (signed a MOU with the Rajasthan Government aimed at developing Rajasthan as the global hub for solar energy), TSLA +3% (Elon Musk tweets 'Article in WSJ re Tesla sales is incorrect), DRRX +2.6% (following ~45% move lower yesterday on Remoxy news),TOT +2.1% (sells an 8% interest in Gina Krog Field and interests in three minor fields), ANGI +2% (Director disclosed purchase of 15000 shares, worth total of $98.4K), CNI +0.9% (announces plan to buy back shares through private agreements), CRAY +0.9% (awarded $128 mln supercomputer contract from the UK's Met office)
Analyst comments: GPRO +3.3% (initiated with a Outperform at Wedbush), FMSA +2.3% (initiated with an Outperform at Cowen, initiated with a Buy at KeyBanc Capital Mkts amont others), DRYS +1.9% (upgraded to Outperform at Imperial Capital), CRM +1.5% (added to Best Ideas list at Morgan Stanley), CELG +1.5% (added to US 1 list at BofA/Merrill), YDLE +1.1% (initiated with a Buy at Goldman, among others)